US5560922A
(en)
*
|
1986-05-30 |
1996-10-01 |
Rutgers, The State University Of New Jersey |
Transdermal absorption dosage unit using a polyacrylate adhesive polymer and process
|
US5229129A
(en)
*
|
1989-07-12 |
1993-07-20 |
Cygnus Therapeutic Systems |
Transdermal administration of lisuride
|
NZ237241A
(en)
*
|
1990-03-02 |
1993-11-25 |
Pharmetrix Corp |
Method for increasing the storage stability of physostigmine
|
EP0523150A4
(en)
*
|
1990-04-06 |
1993-09-29 |
Pharmetrix Corporation |
Device and method for enhanced administration of physostigmine
|
US5225198A
(en)
*
|
1991-08-27 |
1993-07-06 |
Cygnus Therapeutic Systems |
Transdermal administration of short or intermediate half-life benzodiazepines
|
US5705185A
(en)
*
|
1991-09-25 |
1998-01-06 |
Beta Pharmaceuticals Co. |
Transdermal delivery of estradiol and process for manufacturing said device
|
US5518734A
(en)
*
|
1991-09-25 |
1996-05-21 |
Beta Pharmaceuticals Co. |
Transdermal delivery system for estradiol and process for manufacturing said device
|
US5229130A
(en)
*
|
1991-12-20 |
1993-07-20 |
Cygnus Therapeutics Systems |
Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems
|
US5453279A
(en)
*
|
1992-04-21 |
1995-09-26 |
Tbs Laboratories, Inc. |
Enhancing transdermal absorption compositions; transdermal dosage form; and process
|
US6676967B1
(en)
|
1993-09-20 |
2004-01-13 |
Kos Pharmaceuticals, Inc. |
Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
|
US6746691B2
(en)
|
1993-09-20 |
2004-06-08 |
Kos Pharmaceuticals, Inc. |
Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
|
US6818229B1
(en)
|
1993-09-20 |
2004-11-16 |
Kos Pharmaceuticals, Inc. |
Intermediate release nicotinic acid compositions for treating hyperlipidemia
|
US6080428A
(en)
|
1993-09-20 |
2000-06-27 |
Bova; David J. |
Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
|
JPH0827003A
(ja)
*
|
1994-07-22 |
1996-01-30 |
Sekisui Chem Co Ltd |
経皮吸収製剤
|
CA2198390C
(en)
|
1994-09-14 |
2009-08-11 |
James E. Garbe |
Matrix for transdermal drug delivery
|
GB9500116D0
(en)
*
|
1995-01-05 |
1995-03-01 |
Ciba Geigy Ag |
Pharmaceutical compositions
|
US5573778A
(en)
*
|
1995-03-17 |
1996-11-12 |
Adhesives Research, Inc. |
Drug flux enhancer-tolerant pressure sensitive adhesive composition
|
US5882676A
(en)
*
|
1995-05-26 |
1999-03-16 |
Alza Corporation |
Skin permeation enhancer compositions using acyl lactylates
|
US6572879B1
(en)
*
|
1995-06-07 |
2003-06-03 |
Alza Corporation |
Formulations for transdermal delivery of pergolide
|
EP1563788B8
(en)
|
1995-08-29 |
2015-04-08 |
Nitto Denko Corporation |
Microporation of human skin for drug delivery and monitoring applications
|
DE19548332A1
(de)
*
|
1995-12-22 |
1997-07-10 |
Rotta Res Bv |
Hormonpflaster
|
WO1997034607A1
(en)
*
|
1996-03-20 |
1997-09-25 |
Glaxo Group Limited |
Topical formulations of aciclovir
|
IT1283102B1
(it)
*
|
1996-06-06 |
1998-04-07 |
Permatec Nv |
Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele
|
ES2191834T3
(es)
*
|
1996-10-24 |
2003-09-16 |
Alza Corp |
Agentes que facilitan la permeacion y destinados para composiciones, dispositivos y procedimientos de aporte transdermico de medicamentos.
|
EP0971662A1
(en)
*
|
1996-10-30 |
2000-01-19 |
TheraTech, Inc. |
Fatty acid esters of glycolic acid and its salts as permeation enhancers
|
KR100215027B1
(ko)
*
|
1997-01-27 |
1999-08-16 |
성재갑 |
스테로이드계 약물의 경피흡수투여용 조성물 및 이를 포함하는 경피흡수투여용 제형
|
KR100294084B1
(ko)
*
|
1998-06-02 |
2001-09-22 |
성재갑 |
비-스테로이드성소염진통제의경피흡수투여용조성물및이를포함하는경피흡수투여용제형
|
US6572874B1
(en)
*
|
1998-05-15 |
2003-06-03 |
Umd, Inc. |
Vaginal delivery of bisphosphonates
|
IT1294748B1
(it)
|
1997-09-17 |
1999-04-12 |
Permatec Tech Ag |
Formulazione per un dispositivo transdermico
|
US6414028B1
(en)
|
1997-11-05 |
2002-07-02 |
Nexmed Holdings, Inc. |
Topical compositions containing prostaglandin E1
|
US6046244A
(en)
*
|
1997-11-05 |
2000-04-04 |
Nexmed Holdings, Inc. |
Topical compositions for prostaglandin E1 delivery
|
AU1728099A
(en)
|
1997-12-22 |
1999-07-12 |
Alza Corporation |
Monoglyceride and ethyl palmitate permeation enhancer compositions
|
DE19814084B4
(de)
*
|
1998-03-30 |
2005-12-22 |
Lts Lohmann Therapie-Systeme Ag |
D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
|
AU749475B2
(en)
*
|
1998-04-27 |
2002-06-27 |
Astellas Pharma Inc. |
Medicinal compositions
|
FR2761600B1
(fr)
|
1998-06-19 |
2000-03-31 |
Oreal |
Composition moussante pour le lavage et le traitement des cheveux et/ou du cuir chevelu a base d'un principe actif, d'un tensioactif anionique, d'un tensioactif amphotere et d'un agent propenetrant
|
GB9825402D0
(en)
†
|
1998-11-19 |
1999-01-13 |
Pfizer Ltd |
Antiparasitic formulations
|
US20030078499A1
(en)
*
|
1999-08-12 |
2003-04-24 |
Eppstein Jonathan A. |
Microporation of tissue for delivery of bioactive agents
|
USRE44145E1
(en)
|
2000-07-07 |
2013-04-09 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
|
US20070225379A1
(en)
*
|
2001-08-03 |
2007-09-27 |
Carrara Dario Norberto R |
Transdermal delivery of systemically active central nervous system drugs
|
WO2005039531A1
(en)
|
2003-10-10 |
2005-05-06 |
Antares Pharma Ipl Ag |
Transdermal pharmaceutical formulation for minimizing skin residues
|
ES2283665T3
(es)
*
|
2000-08-03 |
2007-11-01 |
Antares Pharma Ipl Ag |
Composicion para administracion transdermica y/o transmucosa de compuestos activos que asegura unos niveles terapeuticamente adecuados.
|
US7198801B2
(en)
|
2000-08-03 |
2007-04-03 |
Antares Pharma Ipl Ag |
Formulations for transdermal or transmucosal application
|
US8980290B2
(en)
|
2000-08-03 |
2015-03-17 |
Antares Pharma Ipl Ag |
Transdermal compositions for anticholinergic agents
|
US20040198706A1
(en)
*
|
2003-03-11 |
2004-10-07 |
Carrara Dario Norberto R. |
Methods and formulations for transdermal or transmucosal application of active agents
|
DE10041478A1
(de)
|
2000-08-24 |
2002-03-14 |
Sanol Arznei Schwarz Gmbh |
Neue pharmazeutische Zusammensetzung
|
US20050113510A1
(en)
|
2001-05-01 |
2005-05-26 |
Feldstein Mikhail M. |
Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
|
US8840918B2
(en)
|
2001-05-01 |
2014-09-23 |
A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences |
Hydrogel compositions for tooth whitening
|
US8541021B2
(en)
|
2001-05-01 |
2013-09-24 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Hydrogel compositions demonstrating phase separation on contact with aqueous media
|
US20050215727A1
(en)
|
2001-05-01 |
2005-09-29 |
Corium |
Water-absorbent adhesive compositions and associated methods of manufacture and use
|
CA2445086C
(en)
|
2001-05-01 |
2008-04-08 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Hydrogel compositions
|
US8206738B2
(en)
|
2001-05-01 |
2012-06-26 |
Corium International, Inc. |
Hydrogel compositions with an erodible backing member
|
ATE502657T1
(de)
|
2001-05-01 |
2011-04-15 |
Av Topchiev Inst Petrochemical |
Zweiphasige, wasserabsorbierende bioadhäsive zusammenstezung
|
PL210514B1
(pl)
*
|
2001-11-29 |
2012-01-31 |
3M Innovative Properties Co |
Preparat farmaceutyczny zawierający modyfikator odpowiedzi immunologicznej
|
DE10159120B4
(de)
*
|
2001-12-01 |
2006-08-17 |
Lts Lohmann Therapie-Systeme Ag |
Steroidhormonhaltige transdermale therapeutische Systeme enthaltend Propylenglycolmonocaprylat und seine Verwendung
|
US20040033253A1
(en)
*
|
2002-02-19 |
2004-02-19 |
Ihor Shevchuk |
Acyl opioid antagonists
|
US9918665B2
(en)
|
2002-03-11 |
2018-03-20 |
Nitto Denko Corporation |
Transdermal porator and patch system and method for using same
|
EP1483019A4
(en)
|
2002-03-11 |
2007-07-04 |
Altea Therapeutics Corp |
TRANSDERMALES MEDICAMENT PAVING SYSTEM, METHOD FOR THE PRODUCTION THEREOF AND METHOD FOR THE APPLICATION THEREOF
|
US8116860B2
(en)
*
|
2002-03-11 |
2012-02-14 |
Altea Therapeutics Corporation |
Transdermal porator and patch system and method for using same
|
US20030199584A1
(en)
*
|
2002-04-11 |
2003-10-23 |
Ahluwalia Gurpreet S. |
Reduction of hair growth
|
US8211462B2
(en)
*
|
2002-07-30 |
2012-07-03 |
Ucb Pharma Gmbh |
Hot-melt TTS for administering rotigotine
|
DE10234673B4
(de)
*
|
2002-07-30 |
2007-08-16 |
Schwarz Pharma Ag |
Heißschmelz-TTS zur Verabreichung von Rotigotin und Verfahren zu seiner Herstellung sowie Verwendung von Rotigotin bei der Herstellung eines TTS im Heißschmelzverfahren
|
US8246979B2
(en)
|
2002-07-30 |
2012-08-21 |
Ucb Pharma Gmbh |
Transdermal delivery system for the administration of rotigotine
|
US8246980B2
(en)
*
|
2002-07-30 |
2012-08-21 |
Ucb Pharma Gmbh |
Transdermal delivery system
|
ATE423560T1
(de)
*
|
2002-08-20 |
2009-03-15 |
Euro Celtique Sa |
Transdermale dosierungsform enthaltend einen wirkstoff und einen antagonisten in freier base und in salz form
|
EP1556501A4
(en)
|
2002-10-28 |
2009-04-08 |
Transform Pharmaceuticals Inc |
TRANSDERMALER ASSAY WITH MAGNETIC TERMINAL
|
DK1426049T3
(da)
*
|
2002-12-02 |
2005-08-22 |
Sanol Arznei Schwarz Gmbh |
Iontophoretisk tilförsel af rotigotin til behandling af Parkinsons sygdom
|
CA2729967C
(en)
*
|
2002-12-13 |
2018-01-16 |
Schering-Plough Healthcare Products, Inc. |
Use of a transdermal or transmucosal ingredient delivery device
|
JP4542743B2
(ja)
*
|
2002-12-26 |
2010-09-15 |
Kdl株式会社 |
ピリドン誘導体の溶液状医薬組成物
|
DE10261696A1
(de)
*
|
2002-12-30 |
2004-07-15 |
Schwarz Pharma Ag |
Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base
|
US7858607B2
(en)
*
|
2003-03-14 |
2010-12-28 |
Mamchur Stephen A |
System for use by compounding pharmacists to produce hormone replacement medicine customized for each consumer
|
US20040241223A1
(en)
*
|
2003-05-27 |
2004-12-02 |
David Wong |
Oral dosage forms for macromolecular drugs
|
US7576226B2
(en)
*
|
2003-06-30 |
2009-08-18 |
Richter Gedeon Vegyeszeti Gyar Rt. |
Process of making isomers of norelgestromin and methods using the same
|
EP1648363B1
(en)
|
2003-07-03 |
2019-03-06 |
Corium International, Inc. |
Wound dressing, ingredient delivery device and iv hold-down, and method relating to same
|
US20080020028A1
(en)
*
|
2003-08-20 |
2008-01-24 |
Euro-Celtique S.A. |
Transdermal dosage form comprising an active agent and a salt and a free-base form of an adverse agent
|
US8016811B2
(en)
|
2003-10-24 |
2011-09-13 |
Altea Therapeutics Corporation |
Method for transdermal delivery of permeant substances
|
US7105263B2
(en)
*
|
2003-12-30 |
2006-09-12 |
Samsung Electronics Company |
Dry toner comprising encapsulated pigment, methods and uses
|
RU2380092C2
(ru)
|
2004-01-30 |
2010-01-27 |
Кориум Интернэшнл, Инк. |
Быстро растворяющаяся пленка для доставки активного агента
|
WO2005077364A1
(ja)
*
|
2004-02-18 |
2005-08-25 |
Yamanouchi Pharmaceutical Co., Ltd. |
ソリフェナシンの経皮投与製剤およびその経皮透過改善方法
|
US7425340B2
(en)
*
|
2004-05-07 |
2008-09-16 |
Antares Pharma Ipl Ag |
Permeation enhancing compositions for anticholinergic agents
|
US20060008432A1
(en)
*
|
2004-07-07 |
2006-01-12 |
Sebastiano Scarampi |
Gilsonite derived pharmaceutical delivery compositions and methods: nail applications
|
US20080028990A1
(en)
*
|
2004-07-15 |
2008-02-07 |
Freedom-2, Llc |
Modified Tissue Marking Pigment And Method For Modifying Tissue Marking Pigment
|
CA2576158C
(en)
|
2004-08-05 |
2020-10-27 |
Corium International, Inc. |
Adhesive composition
|
EP2338881A1
(en)
|
2005-02-23 |
2011-06-29 |
Prexa Pharmaceuticals, Inc. |
Dopamine transporter inhibitors for use in treatment of movement disorders and other CNS indications
|
US8067399B2
(en)
|
2005-05-27 |
2011-11-29 |
Antares Pharma Ipl Ag |
Method and apparatus for transdermal or transmucosal application of testosterone
|
US20070065494A1
(en)
*
|
2005-08-03 |
2007-03-22 |
Watson Laboratories, Inc. |
Formulations and Methods for Enhancing the Transdermal Penetration of a Drug
|
US10137135B2
(en)
|
2005-08-15 |
2018-11-27 |
Allergan Sales, Llc |
Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith
|
CA2646667C
(en)
|
2006-04-21 |
2014-03-11 |
Antares Pharma Ipl Ag |
Methods of treating hot flashes with formulations for transdermal or transmucosal application
|
DE102006050558B4
(de)
|
2006-10-26 |
2009-03-26 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales therapeutisches System enthaltend Norelgestromin zur Kontrazeption und Hormonsubstitution
|
WO2009018356A1
(en)
*
|
2007-07-30 |
2009-02-05 |
Medacure International, Inc. |
Immune system modulator formulation
|
US20090098191A1
(en)
*
|
2007-10-16 |
2009-04-16 |
Anderson Christopher G |
Use of bases to stabilize transdermal formulations
|
WO2009143174A2
(en)
*
|
2008-05-19 |
2009-11-26 |
Children's Medical Center Corporation |
Chemical permeation enhancers enhance nerve blockade by toxins
|
WO2009143175A2
(en)
*
|
2008-05-19 |
2009-11-26 |
Children's Medical Center Corporation |
Sensory-specific local anesthesia and prolonged duration local anesthesia
|
EP2387394B1
(en)
|
2009-01-14 |
2018-05-02 |
Corium International, Inc. |
Transdermal administration of tamsulosin
|
US20110288389A9
(en)
|
2009-03-02 |
2011-11-24 |
Seventh Sense Biosystems, Inc. |
Oxygen sensor
|
WO2010101620A2
(en)
*
|
2009-03-02 |
2010-09-10 |
Seventh Sense Biosystems, Inc. |
Systems and methods for creating and using suction blisters or other pooled regions of fluid within the skin
|
US9295417B2
(en)
|
2011-04-29 |
2016-03-29 |
Seventh Sense Biosystems, Inc. |
Systems and methods for collecting fluid from a subject
|
US8957207B2
(en)
|
2009-03-24 |
2015-02-17 |
Proteus S.A. |
Methods for producing phycotoxins
|
WO2011000210A1
(zh)
*
|
2009-07-01 |
2011-01-06 |
润和生物医药科技(汕头)有限公司 |
促渗剂组合物及其透皮给药系统中的应用
|
WO2011017520A1
(en)
|
2009-08-05 |
2011-02-10 |
Wake Forest University Health Sciences |
Compositions and methods for inducing apoptosis in prostate cancer cells
|
WO2011094573A1
(en)
|
2010-01-28 |
2011-08-04 |
Seventh Sense Biosystems, Inc. |
Monitoring or feedback systems and methods
|
CN103180318B
(zh)
|
2010-05-14 |
2017-05-10 |
达那-法伯癌症研究所 |
雄性避孕组合物以及使用方法
|
WO2011163347A2
(en)
|
2010-06-23 |
2011-12-29 |
Seventh Sense Biosystems, Inc. |
Sampling devices and methods involving relatively little pain
|
JP2013538069A
(ja)
|
2010-07-16 |
2013-10-10 |
セブンス センス バイオシステムズ,インコーポレーテッド |
流体移動デバイスのための低圧環境
|
US20130158482A1
(en)
|
2010-07-26 |
2013-06-20 |
Seventh Sense Biosystems, Inc. |
Rapid delivery and/or receiving of fluids
|
US20120039809A1
(en)
|
2010-08-13 |
2012-02-16 |
Seventh Sense Biosystems, Inc. |
Systems and techniques for monitoring subjects
|
EP2637562B1
(en)
|
2010-11-09 |
2016-01-27 |
Seventh Sense Biosystems, Inc. |
Systems and interfaces for blood sampling
|
US20130158468A1
(en)
|
2011-12-19 |
2013-06-20 |
Seventh Sense Biosystems, Inc. |
Delivering and/or receiving material with respect to a subject surface
|
EP2702406B1
(en)
|
2011-04-29 |
2017-06-21 |
Seventh Sense Biosystems, Inc. |
Plasma or serum production and removal of fluids under reduced pressure
|
AU2012249692A1
(en)
|
2011-04-29 |
2013-11-14 |
Seventh Sense Biosystems, Inc. |
Delivering and/or receiving fluids
|
AU2012297609A1
(en)
*
|
2011-08-25 |
2014-03-27 |
Nipro Patch Co., Ltd. |
Hydrous adhesive skin patch
|
DE102011119043A1
(de)
|
2011-11-22 |
2013-05-23 |
Alfred E. Tiefenbacher (Gmbh & Co. Kg) |
Transdermales therapeutisches System (TDS) mit Rotigotin
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
LT2782584T
(lt)
|
2011-11-23 |
2021-09-10 |
Therapeuticsmd, Inc. |
Natūralios kombinuotos pakaitinės hormonų terapijos kompozicijos ir gydymas
|
CA2861346C
(en)
*
|
2012-01-26 |
2020-04-07 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US20130338122A1
(en)
*
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
WO2014113541A1
(en)
|
2013-01-16 |
2014-07-24 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Attenuated chlamydia vaccine
|
KR20220132666A
(ko)
|
2013-03-15 |
2022-09-30 |
더 칠드런스 메디칼 센터 코포레이션 |
지속성 국소 마취용 네오삭시톡신 조합 제형
|
AU2014251207B2
(en)
|
2013-04-07 |
2019-06-13 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for personalized neoplasia vaccines
|
EA201691057A1
(ru)
|
2013-11-22 |
2016-10-31 |
Джензим Корпорейшн |
Новые способы лечения нейродегенеративных заболеваний
|
WO2015077717A1
(en)
|
2013-11-25 |
2015-05-28 |
The Broad Institute Inc. |
Compositions and methods for diagnosing, evaluating and treating cancer by means of the dna methylation status
|
US11725237B2
(en)
|
2013-12-05 |
2023-08-15 |
The Broad Institute Inc. |
Polymorphic gene typing and somatic change detection using sequencing data
|
JP7060324B2
(ja)
|
2013-12-20 |
2022-04-26 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
ネオ抗原ワクチンによる併用療法
|
AU2015264003A1
(en)
|
2014-05-22 |
2016-11-17 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
KR20170040209A
(ko)
|
2014-07-29 |
2017-04-12 |
쎄러퓨틱스엠디, 인코퍼레이티드 |
경피 크림
|
US10993997B2
(en)
|
2014-12-19 |
2021-05-04 |
The Broad Institute, Inc. |
Methods for profiling the t cell repertoire
|
US10975442B2
(en)
|
2014-12-19 |
2021-04-13 |
Massachusetts Institute Of Technology |
Molecular biomarkers for cancer immunotherapy
|
TW202346325A
(zh)
|
2015-05-20 |
2023-12-01 |
美商博德研究所有限公司 |
共有之gata3相關之腫瘤特異性新抗原
|
US20170000745A1
(en)
*
|
2015-07-02 |
2017-01-05 |
Noven Pharmaceuticals, Inc. |
Transdermal drug delivery systems for levonorgestrel and ethinyl estradiol
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
US9931349B2
(en)
|
2016-04-01 |
2018-04-03 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical composition
|
US10286077B2
(en)
|
2016-04-01 |
2019-05-14 |
Therapeuticsmd, Inc. |
Steroid hormone compositions in medium chain oils
|
AU2017254477A1
(en)
|
2016-04-18 |
2018-11-01 |
Jennifer G. ABELIN |
Improved HLA epitope prediction
|
EP3574116A1
(en)
|
2017-01-24 |
2019-12-04 |
The Broad Institute, Inc. |
Compositions and methods for detecting a mutant variant of a polynucleotide
|
WO2020072700A1
(en)
|
2018-10-02 |
2020-04-09 |
Dana-Farber Cancer Institute, Inc. |
Hla single allele lines
|
US20220062394A1
(en)
|
2018-12-17 |
2022-03-03 |
The Broad Institute, Inc. |
Methods for identifying neoantigens
|